Shaily Engineering Plastics

Shaily Engineering Plastics share price has fallen 24% in three months and has dropped 7% in six months. However, the smallcap stock has risen 32% in one year, and has delivered multibagger returns of 283% in two years.

Shaily Engineering, with a market cap of ₹ 8,921 crore, secured a ₹ 423 crore contract for pen injectors with a major pharma firm. Despite recent stock struggles, the company reported a net profit increase to ₹ 37 crore year-on-year, although it faced a sequential decline.

Shaily Engineering Plastics Ltd and Gland Pharma Ltd, involved in the making and filling of injectable pens for semaglutide, stand to win big as patients will need these devices irrespective of which brand of the drug they choose.

UBS has initiated coverage of Shaily Engineering Plastics with a 'Buy' rating and a target price of ₹ 4,000, indicating a 60% upside. The firm highlights Shaily's patented technology and strong market position for GLP-1 therapies, estimating substantial revenue growth and a 75% EPS CAGR by FY28.

Foreign investors are quietly raising stakes in three companies even as domestic institutional investors and retail investors book profits — a rare divergence that may signal early conviction, though not yet a lasting trend.

As of September 2025, Ashish Kacholia’s portfolio comprises 42 stocks valued at around ₹ 2,088 crore, with the largest holding in Shaily Engineering Plastics, where he owns 14.79 lakh shares, representing a 3.22% stake valued at ₹ 366.2 crore.

Sumeet Bagadia recommends five breakout stocks to buy today: KRN Heat Exchanger and Refrigeration, Avantel, Shaily Engineering Plastics, Datamatics Global Services, and Fedbank Financial Services.

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — R R Kabel, Sudarshan Chemical Industries, Shaily Engineering Plastics, Wockhardt, and Prudent Corporate Advisory Services.